Debjit Chattopadhyay

Stock Analyst at Guggenheim

(0.82)
# 2032
Out of 5,321 analysts
103
Total ratings
33.33%
Success rate
-4.14%
Average return
Main Sectors:
Top Industries:
37 Stocks
Name Action Price Target Current % Upside Ratings Updated
IONS Ionis Pharmaceutical...
Reiterates: Buy
n/a
n/a n/a 4 Apr 3, 2025
MAZE Maze Therapeutics
Reiterates: Buy
19 19
8.98 111.58% 2 Apr 2, 2025
SLNO Soleno Therapeutics
Maintains: Strong Buy
70 81
71.69 12.99% 2 Mar 28, 2025
CNTA Centessa Pharmaceuti...
Reiterates: Buy
28 28
13.29 110.68% 6 Mar 26, 2025
BEAM Beam Therapeutics
Reiterates: Buy
78 78
19.71 295.74% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 4 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 5 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
1.77 916.95% 3 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
17 17
13.88 22.48% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
7.13 110.38% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
450 558
489.82 13.92% 6 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
5.57 241.11% 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
3.5 528.57% 1 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
130 175
165.46 5.77% 3 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
17.21 74.32% 1 Jan 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
110
62.6 75.72% 3 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 29
1.58 1735.44% 1 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 11
0.33 3233.33% 2 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
50
37.33 33.94% 2 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 51
54.99 -7.26% 4 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
1.8 1455.56% 1 Dec 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
170
8.15 1985.89% 1 Oct 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
255
n/a n/a 1 May 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
20
6.68 199.4% 2 Dec 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
11
n/a n/a 5 Dec 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 221
60.7 264.09% 4 Aug 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
270 123
26.16 370.18% 8 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 54
12.43 334.43% 3 Jul 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
420 156
n/a n/a 3 Mar 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
60
1.48 3954.05% 3 Dec 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
75 90
n/a n/a 5 Nov 26, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 4
n/a n/a 2 Mar 4, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 26, 2017